Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

Jubb, Becky;Lewis, Marilyn;McFadyen, Lynn;Simpson, Paul;Mori, Julie;Chan, Phylinda;Weatherley, Barry;van der Ryst, Elna;Westby, Mike;Craig, Charles;
antiviral chemistry & chemotherapy Vol. 27 pp. 2040206619895706
399
jubbincidenceantiviral

Citation

ID: 80136
Ref Key: jubbincidenceantiviral
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
80136
Unique Identifier:
10.1177/2040206619895706
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
3/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Saymatik Web3.0 Wallet